0.611
0.79%
-0.0031
前日終値:
$0.6079
開ける:
$0.6
24時間の取引高:
144.82K
Relative Volume:
0.72
時価総額:
$28.53M
収益:
$27.75M
当期純損益:
$-25.07M
株価収益率:
-1.175
EPS:
-0.52
ネットキャッシュフロー:
$-32.64M
1週間 パフォーマンス:
-4.42%
1か月 パフォーマンス:
-25.99%
6か月 パフォーマンス:
-23.58%
1年 パフォーマンス:
-12.59%
Orgenesis Inc Stock (ORGS) Company Profile
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2018-12-20 | 開始されました | Dawson James | Buy |
Orgenesis Inc (ORGS) 最新ニュース
Artificial Insemination Market May See Big Move: Vitrolife, Orgenesis, CryoLife - openPR
Cell therapy weekly: US FDA grants Orphan Drug Designation to a gene therapy for a type of retinal disease - RegMedNet
Orgenesis Inc (ORGS) is looking forward to a strong quarter - SETE News
Upward Trajectory: Orgenesis Inc (ORGS) Posts a Slidee, Closing at 0.67 - The Dwinnex
Orgenesis’ CAR-T ORG-101 Demonstrates Efficacy and Safety in Acute Lymphoblastic Leukemia in Real-World Study in China - CGTLive™
Orgenesis reports promising CAR-T therapy results - Investing.com India
Orgenesis Releases Investor Presentation and Regulatory Update - TipRanks
Orgenesis reports promising CAR-T therapy results - Investing.com
Orgenesis reports promising CAR-T therapy results By Investing.com - Investing.com UK
Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - StockTitan
Orgenesis Inc. secures additional $750K funding - Investing.com India
Orgenesis Inc. secures additional $750K funding By Investing.com - Investing.com Canada
Orgenesis Inc. secures additional $750K funding By Investing.com - Investing.com UK
Pfizer Does Not Own Orgenesis: So Why Does This Misinformation Trend on X? - PANDA
Orgenesis Inc (ORGS) can make a big difference with a little luck - SETE News
Orgenesis stock hits 52-week high at $1.04 amid market fluctuations - Investing.com
Orgenesis forms joint venture with Harley Street Healthcare Group - Investing.com
Orgenesis forms joint venture with Harley Street Healthcare Group - Investing.com India
Orgenesis forms joint venture with Harley Street Healthcare - Investing.com
Orgenesis forms joint venture with Harley Street Healthcare - Investing.com India
Orgenesis Inc Inc. (ORGS) Price Performance: The Impact of Insider Trading and Institutional Holdings - The InvestChronicle
Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - StockTitan
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Orgenesis Provides Second Quarter 2024 Business Update - ForexTV.com
Orgenesis Provides Second Quarter 2024 Business Update - StockTitan
BioIVT Opens Facility With New Cleanroom From Germfree In Winchester VA - Pharmaceutical Online
Who are the leading innovators in GLP-1 analogues for the pharmaceutical industry? - Pharmaceutical Technology
Orgenesis Inc [ORGS] Investment Guide: What You Need to Know - Knox Daily
Investor’s Delight: Orgenesis Inc (ORGS) Closes Strong at 0.64, Up 14.64 - The Dwinnex
Orgenesis (NASDAQ:ORGS) Shares Up 14.6% - Defense World
ORGS: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Check Out Kintara Therapeutics Inc (KTRA)’s Trade Data Rather Than the Analysts’ Views - SETE News
Anixa Biosciences Secures FDA Clearance to Redose Single Patient in Ovarian Cancer CER-T Trial - CGTLive™
No, Ursula von der Leyen's husband does not work for a company owned by Pfizer - logicallyfacts.com
Common Warts Treatment Market Statistical Forecast, Trade Analysis 2024 – 2031 - WhaTech
Oncolytic Virus Cancer Therapy Pipeline Report 2024: Companies, Therapies, Latest FDA, EMA, Approvals by - EIN News
Orgenesis Announces Board Reshuffle and New Audit Member - TipRanks
Regenerative Xenograft Market Revenue and Size Outlook | Organovo Holdings Inc, Athersys Inc, RenovaCare Inc ... - Economica
Onconase (Ranpirnase) | Benefits and Side Effects - Mesothelioma.net Blog
FlexShopper director Howard Dvorkin buys $20,023 in company stock By Investing.com - Investing.com India
Orgenesis Inc. expands equity incentive plan by 9 million shares By Investing.com - Investing.com Australia
Orgenesis Inc. expands equity incentive plan by 9 million shares By Investing.com - Investing.com Canada
Orgenesis Inc. expands equity incentive plan by 9 million shares By Investing.com - Investing.com
Orgenesis Annual Meeting: Board Changes and Share Increase - TipRanks
Investing in Orgenesis Inc (ORGS): What You Must Know – Knox Daily - Knox Daily
ORGS’s Stock Journey: What Investors Need to Know About Orgenesis Inc’s Performance - The InvestChronicle
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day ... - Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Short Interest in Orgenesis Inc. (NASDAQ:ORGS) Decreases By 17.6% - Defense World
Form 424B3 Orgenesis Inc. - StreetInsider.com
Orgenesis (NASDAQ:ORGS) Stock Price Down 2.4% - Defense World
Orgenesis Inc (ORGS) 財務データ
収益
当期純利益
現金流量
EPS
Orgenesis Inc (ORGS) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Safier Jacob | 10% Owner |
Feb 01 '24 |
Buy |
0.33 |
10,100 |
3,332 |
3,110,100 |
Safier Jacob | 10% Owner |
Sep 21 '23 |
Buy |
0.69 |
100,000 |
68,950 |
2,839,860 |
Safier Jacob | 10% Owner |
Nov 02 '23 |
Buy |
0.84 |
20,000 |
16,888 |
2,920,000 |
Safier Jacob | 10% Owner |
Sep 28 '23 |
Buy |
0.67 |
25,000 |
16,780 |
2,864,860 |
Safier Jacob | 10% Owner |
Nov 08 '23 |
Buy |
0.71 |
20,000 |
14,188 |
2,940,000 |
Safier Jacob | 10% Owner |
Nov 09 '23 |
Buy |
0.65 |
20,000 |
13,054 |
2,960,000 |
Safier Jacob | 10% Owner |
Oct 24 '23 |
Buy |
0.90 |
10,000 |
8,999 |
2,890,563 |
Safier Jacob | 10% Owner |
Jan 30 '24 |
Buy |
0.33 |
25,000 |
8,245 |
3,095,000 |
Safier Jacob | 10% Owner |
Oct 05 '23 |
Buy |
0.80 |
10,000 |
8,030 |
2,874,860 |
Safier Jacob | 10% Owner |
Jan 26 '24 |
Buy |
0.32 |
25,000 |
8,000 |
3,070,000 |
大文字化:
|
ボリューム (24 時間):